Why are global drug developers choosing Australia to expedite clinical trials? (The answer goes beyond regulations.) Australia is known for its efficient trial environment, but navigating its unique landscape requires expertise. In this article, we explore the processes, partnerships, and precision that allow us to get trials up and running faster than ever. Read up on down under: https://hubs.ly/Q02Z1NTC0 #australia #clinicaltrials #clinicalresearch
关于我们
Precision for Medicine is an industry-leading global clinical research services organization, purpose-built to improve the clinical research and development process for new therapeutics. Our novel approach integrates clinical operations excellence, with laboratory expertise, and advanced data sciences to inform every step. This maximizes our clients’ insight into patient biology, delivering more predictable trial outcomes and accelerating clinical development. We apply our expertise to trials at all stages—from early development through approval—with embedded experience in oncology and rare disease. With over 2000 dedicated professionals and 35 offices worldwide, we stand ready to help accelerate life-changing treatments anywhere around the globe.
- 网站
-
https://www.precisionformedicine.com
Precision For Medicine的外部链接
- 所属行业
- 生物技术研究
- 规模
- 1,001-5,000 人
- 总部
- Bethesda，MD
- 类型
- 私人持股
- 领域
- Global Clinical Trial Services、Specialty Lab Services、Translational Science、Clinical Data Management、Biostatistics、Biomarker Strategies、Sample Sourcing and Storage、Immune Monitoring、IVD Development、CDx Development、Market Access、IVD CRO、Regulatory Strategy and Submission和Contract Research Organization
地点
Precision For Medicine员工
动态
-
The Precision team would love to meet you at EBF this week! Stop by Booth 2H or reach out to set up time to speak with Mandy Higgins or Astrid Grunwald.
-
-
Is your lab future-ready? Become more confident about your state of readiness with pragmatic insights from our Chief Scientific Officer, Deb Phippard, in her new article in Today's Clinical Lab. https://hubs.ly/Q02YVqND0 #biomarkers #precisionmedicine #clinicaltrials #oncology
-
-
Check out the latest video from Project Farma (PF) President Anshul Mangal as he covers key developments shaping biotech and pharma manufacturing. Key highlights: - Election Impacts - CAR-T Investment Surge - Radiopharma Advancements How do you see these changes influencing the future of biotech? Drop your thoughts in the comments! #ManufacturingMilestones #Biotech #CAR-T #Radiopharma #IndustryInsights
-
Exciting news coming out of AMP 2024: Announcing a strategic partnership and presentation with Agena Bioscience to bridge critical gaps in detecting mutations not identified by next-generation sequencing (NGS) alone. https://hubs.ly/Q02YV2-10 #AMP #next-generation sequencing
-
-
Harness precision medicine data intelligence with the power of conversation. With QuartzBio's Biomarker Intelligence Platform, we’re changing the way data science and R&D IT teams interact with and extract value from sample and biomarker data with 360° intelligence. Learn more at https://hubs.ly/Q02YHC9f0 #datascience #biopharma #clinicaltrials #AI
-
???????? ????????????????! In this webinar, Precision for Medicine experts will reveal how a unified immunogenicity strategy can streamline your path to global approval, saving you valuable time and resources. Register now and ask your questions during the live Q&A session! https://hubs.ly/Q02YwMpm0 #genetherapy #clinicaltrials
-
-
If you're attending AMP this week, join Precision for Medicine's Darren W. Davis, PhD and Agena Bioscience as they present methods to rapidly profile tissue samples - including ones which may be challenging for NGS to profile.
-
-
Remote roles give you more control. See what’s open at one of the fastest-growing CROs in the industry. Director, Project Management: https://hubs.ly/Q02Yl36g0 #pharmajobs #clinicalresearch #oncology #womeninscience
-